Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Colombia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20112
20121
20131
20151
20162
20174
20181
20193
20201
20212
20223
20233
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated6
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genentech, Inc.3
AbbVie2
Anthera Pharmaceuticals2
Bristol-Myers Squibb2
EMD Serono Research & Development Institute, Inc.2
MedImmune LLC2
Pfizer2
Alumis Inc1
Beeline Medicines Corporation1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic28
Autoimmune Diseases4
Lupus Erythematosus, Cutaneous3
Lupus Nephritis3
Connective Tissue Diseases2
Immune System Diseases2
Lupus Erythematosus, Discoid2
Proteinuria1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.